Ispire Technology Inc. (ISPR)
| Market Cap | 98.73M -42.0% |
| Revenue (ttm) | 89.46M -38.2% |
| Net Income | -34.17M |
| EPS | -0.60 |
| Shares Out | 57.40M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 46,864 |
| Open | 1.680 |
| Previous Close | 1.710 |
| Day's Range | 1.660 - 1.770 |
| 52-Week Range | 1.190 - 3.870 |
| Beta | 1.83 |
| Analysts | Strong Buy |
| Price Target | 7.50 (+336.05%) |
| Earnings Date | May 7, 2026 |
About ISPR
Ispire Technology Inc. researches, develops, designs, commercializes, sells, markets, and distributes e-cigarettes and cannabis vaping products worldwide under the Ispire and Aspire brands. The company was founded in 2010 and is headquartered in Los Angeles, California. Ispire Technology Inc. is a subsidiary of Pride Worldwide Investment Limited.
Financial Performance
In fiscal year 2025, Ispire Technology's revenue was $127.49 million, a decrease of -16.07% compared to the previous year's $151.91 million. Losses were -$39.24 million, 165.7% more than in 2024.
Financial StatementsAnalyst Summary
According to one analyst, the rating for ISPR stock is "Strong Buy" and the 12-month stock price target is $7.5.
News
Ispire Technology forms joint venture to enter nicotine pouch market
Ispire Technology (ISPR) has entered into a joint venture with Shandong Jincheng Pharma, a global pharmaceutical company, to manufacture and commercialize nicotine pouch products. The joint venture ma...
Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma
Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments LOS ANGELES, May 12, 2026 /PRNewswire/ -- I...
Ispire Technology reports Q3 EPS (17c) vs. (19c) last year
Reports Q3 revenue $18.7M vs. $26.2M last year. Co-CEO Michael Wang commented, “This quarter reflects the successful stabilization of our business and with cash growing sequentially by $468K to $18M,…
Ispire Technology Earnings Call Transcript: Q3 2026
Revenue declined year-over-year but sequential cash increased, reflecting improved discipline and a solid foundation. Malaysia manufacturing and proprietary tech position the business for margin gains and future growth, with profitability targeted in the second half of 2026.
Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2026
Cash Increased Sequentially by $468,000 to $18 Million Plans to Achieve Cash Flow Positive in Second Half of Calendar Year 2026 Business Stabilized Following Strategic Repositioning Phased Roadmap Tar...
Ispire Technology Inc. Schedules Fiscal Third Quarter 2026 Earnings Conference Call
LOS ANGELES, May 1, 2026 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host i...
IKETech Wins "Privacy-Centric Age Assurance Solution of the Year," Recognized for Innovation at Global Industry Awards
Dual honors at GAAS Summit underscore growing regulatory and commercial validation for IKETech's point-of-use, privacy-first compliance platform LOS ANGELES, April 23, 2026 /PRNewswire/ -- IKETech LLC...
IKE Tech Engages FDA on Next-Generation Compliance Infrastructure for ENDS
Companies outline public health case for point-of-use enforcement technologies and call for regulatory framework recognizing compliance software as a tobacco product LOS ANGELES, April 9, 2026 /PRNews...
Ispire highlights market opportunity established by FDA draft guidance
Ispire Technology (ISPR) highlighted the economic value and multi-billion-dollar market opportunity created for its shareholders by the U.S. Food and Drug Administration’s, FDA, newly issued draft gui...
Ispire Highlights Economic Impact of New FDA Guidance on Flavored ENDS Unlocking a $50 Billion Market and Driving Significant Potential Asset Value
FDA establishes first-ever framework for flavored ENDS, recognizing device level age verification as a regulatory requirement FDA guidance unlocks an estimated $50 billion total addressable market, al...
Ispire Technology Inc. to Participate in the 38th Annual ROTH Conference
LOS ANGELES, March 11, 2026 /PRNewswire/ -- Ispire Technology Inc. ( NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today annou...
Ispire Technology Earnings Call Transcript: Q2 2026
Q2 2026 saw revenue decline due to a strategic pivot to high-value nicotine clients, but key metrics like net loss, operating expenses, and accounts receivable improved. Innovations in age-gating and G-Mesh technology, plus Malaysian facility expansion, position the company for future growth.
Ispire Technology reports Q2 (12c) vs. (14c) last year
Sees Q2 revenue $20.3M vs. $41.8M last year. “This quarter represented an inflection point for Ispire during its yearlong cost cutting and customer quality rationalization efforts and we believe futur...
Ispire Technology Inc. Reports Financial Results for Fiscal Second Quarter 2026
Ongoing Focus on Collections Drives 19% Reduction in Net Accounts Receivable since June 30, 2025 Cash of $17.6 Million at December 31, 2025 LOS ANGELES, Feb. 6, 2026 /PRNewswire/ -- Ispire Techno...
Ispire-Backed IKE Tech Invited to Participate in FDA Roundtable on PMTA Submissions
Invitation-Only Forum Underscores FDA Recognition of IKE Tech as a Key Stakeholder and Highlights the Strategic Role of Age-Gating Technology in the Future of ENDS Regulation and Compliance LOS ANGELE...
Ispire Technology Inc. Schedules Fiscal Second Quarter 2026 Earnings Conference Call
LOS ANGELES, Feb. 3, 2026 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will hos...
Ispire Technology Unveils Next-Gen Cannabis Hardware Ecosystem at MJBizCon 2025
Company to Showcase Fully Reengineered Portfolio; Executive Team, Including Head of Sales John Monds, Available for On-Site Meetings LOS ANGELES , Nov. 26, 2025 /PRNewswire/ -- Ispire Technology Inc...
Ispire Technology and IKE Tech Applaud FDA Crackdown, Call for Tech-Driven Enforcement to Prevent Illicit Trade and Protect Youth
LOS ANGELES , Nov. 17, 2025 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), an innovator in vaping technology and precision dosing, and IKE Tech LLC ("IKE Tech"), ...
Ispire Technology Earnings Call Transcript: Q1 2026
Revenue and gross profit declined year-over-year due to a strategic exit from cannabis, but cost controls and a shift to higher-quality customers led to improved net loss and positive non-GAAP EBITDA. Expansion in nicotine technology and manufacturing capacity is expected to drive future growth.
Ispire Technology Inc. Reports Financial Results for Fiscal First Quarter 2026
Cost cutting measures instituted in Fiscal 2025 helped cut total operating expenses by approximately 39% to $7.8 Million year-over-year Net Accounts Receivable Reduced approximately 29% from $62.4 Mil...
Ispire Technology Inc. Schedules Fiscal First Quarter 2026 Earnings Conference Call
LOS ANGELES , Nov. 4, 2025 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will hos...
Ispire Technology Transcript: Planet MicroCap Showcase: TORONTO 2025
A global hardware innovator in nicotine and cannabis sectors, the company is advancing proprietary age-gating technology, expanding manufacturing in Malaysia to boost margins, and targeting major tobacco firms for licensing. Regulatory engagement and product innovation drive growth.
Ispire Technology Transcript: LD Micro Main Event XIX Investor Conference
Revenue reached $127 million with a global footprint and a focus on patented vaping technology. A blockchain-based age-gating solution is under fast-track FDA review, with potential for industry-wide licensing. Malaysian manufacturing expansion and GMESH innovation drive growth.
Ispire Technology Earnings Call Transcript: Q4 2025
Fiscal 2025 saw a strategic pivot from cannabis to nicotine, resulting in lower revenue but improved accounts receivable and significant cost savings. Investments in Malaysian manufacturing and age verification technology position the company for future growth, despite ongoing regulatory and market risks.
Options Volatility and Implied Earnings Moves Today, September 16, 2025
Today, several major companies are expected to report earnings: Evolution Petroleum (EPM), Ferguson PLC (FERG), Ispire Technology, Inc. (ISPR). Ahead of earnings, TipRanks shows you the expected earni...